Skip to content

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03222284
Enrollment
30
Registered
2017-07-19
Start date
2017-07-17
Completion date
2017-11-30
Last updated
2017-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

diabetes, type 2 diabetes, type ii diabetes, insulin, mobile applications, Diabetes Mellitus, Diabetes Mellitus, Type 2, smartphone application, health application

Brief summary

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have either two or three visits at HITLAB during the 28-day study period.

Detailed description

The purpose of this study is to evaluate the utility and user experience of a mobile application, called Cornerstones4Care Powered by Glooko App (C4C), for persons diagnosed with diabetes type 2.Subjects will be asked to use the Cornerstones4Care Powered by Glooko App for an approximately 20 minute monitored demonstration session, followed by a 28-day period of daily engagement with the application.The Cornerstones4Care Powered by Glooko App lets users input nutrition, medication, exercise and other daily information to assist in the management of diabetes type 2. It also has the ability to sync with connected devices, such as blood glucose monitors. Additionally, the application offers a library of educational content for users.

Interventions

DEVICECornerstones4Care Powered by Glooko App

Cornerstones4Care Powered by Glooko App is an iOS or Android smartphone application designed to support diabetes management by offering people with diabetes easily accessible, personalized tools for self-monitoring and education. C4C allows people with diabetes to monitor personal health metrics and blood glucose levels, with the aim to achieve participant behavior changes that may contribute to lower hospitalizations, diabetes-related complications and overall healthcare costs.

Sponsors

Novo Nordisk A/S
CollaboratorINDUSTRY
Healthcare Innovation Technology Lab
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Be diagnosed with type 2 diabetes 2. Live in the New York Metropolitan area 3. Be at least 18 years of age 4. Able to read, write, and speak in English 5. Have an iPhone or Android phone 6. Use a blood glucose meter 7. Regularly take insulin by injection 8. Be willing to follow study requirements for a 28-day period

Exclusion criteria

1. Not be diagnosed with type 2 diabetes 2. Not living in the New York Metropolitan area 3. Be less than 18 years of age 4. Be unable to read, write, and speak in English 5. Not have an iPhone or Android phone 6. Not use a blood glucose meter 7. Not regularly take insulin by injection 8. Be unwilling to follow study requirements for a 28-day period

Design outcomes

Primary

MeasureTime frame
Usage of the Cornerstones4Care Powered by Glooko App as assessed by self-report28 days
Device usability as assessed by the System Usability Scale (SUS)28 days

Countries

United States

Contacts

Primary ContactClaire Gutermuth
C4C@hitlab.org9173492528

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026